Cancer Drug Manufacturers Sue HHS OIG Over Denial Of Part D Patient Assistance Program
Complaint against the US government watchdog agency disputes its conclusion that a proposed cost sharing assistance program in Medicare to be funded by a coalition of cancer drug manufacturers would likely violate the federal anti-kickback statute.
